secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001104659-24-058675
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira proposes $250M convertible note offering due 2029; up to $50M share repurchase
--------------------------------------------------------------------------------

- Proposed offering of $250M aggregate principal of Convertible Senior Notes due 2029, with initial purchasers' option for additional $37.5M.
- Proceeds to repurchase portion of outstanding 0.750% 2025 Notes, fund capped call transactions, and repurchase up to $50M of common stock.
- Capped call transactions expected to reduce dilution upon conversion and offset cash payments in excess of principal amount.
- Entered First Amendment to Credit Agreement to permit $150M share repurchase program and the proposed note offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000110465924058675/0001104659-24-058675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000110465924058675/tm2413714d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-058675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer